Cypress Capital Management (Wyoming)’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-155
Closed -$7K 303
2017
Q4
$7K Hold
155
0.01% 264
2017
Q3
$7K Hold
155
0.01% 225
2017
Q2
$6.09K Sell
155
-50
-24% -$1.89K 0.01% 223
2017
Q1
$7.81K Hold
205
0.01% 216
2016
Q4
$7.69K Hold
205
0.01% 216
2016
Q3
$7.11K Hold
205
0.01% 192
2016
Q2
$6.67K Hold
205
0.01% 184
2016
Q1
$5.89K Hold
205
0.01% 182
2015
Q4
$6.85K Hold
205
0.01% 192
2015
Q3
$5.83K Hold
205
0.01% 200
2015
Q2
$8.3K Hold
205
0.01% 216
2015
Q1
$10.1K Hold
205
0.01% 198
2014
Q4
$9.32K Buy
+205
New +$8.05K 0.01% 191

Other funds holding AVNS

Cypress Capital Management (Wyoming)'s AVNS Position: Q1 2018 in Review

Cypress Capital Management (Wyoming) sold out of Avanos Medical (AVNS) in Q1 2018, closing a stake of 155 shares — an estimated $7K sold.

Cypress Capital Management (Wyoming) first reported a position in AVNS in Q4 2014 and held it in 13 quarters. The position peaked at $10.1K in Q1 2015. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2018.

  • Cypress Capital Management (Wyoming) reported no remaining Avanos Medical position as of Q1 2018 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 155 Avanos Medical shares in Q1 2018, an estimated $7K.
  • Cypress Capital Management (Wyoming) first reported a position in Avanos Medical in Q4 2014 and held it in 13 quarters.
  • Cypress Capital Management (Wyoming)'s Avanos Medical position peaked at $10.1K in Q1 2015.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2018.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2018, filed 3 May 2018.